72.6 F
New York
Monday, May 17, 2021

Carlyle Group [NASDAQ: CG] Announces Acquisition of Unchained Labs

Must read

Oaktree [NASDAQ: OCSL] Announces Pricing of Underwritten Public Offering

Oaktree Specialty Lending Corporation disclosed that it has set the price of an underwritten public offering of $350.0 million aggregate principal amount of...

Black.one Introduces Cryptocurrency Exchange Venture with $10B in Funding

Black.one has disclosed Tuesday that it has launched Bullish Global. Bullish Global is a subsidiary of Black.one. It is a new blockchain-based cryptocurrency exchange...

Pfizer-BioNTech COVID-19 Vaccine Gets FA Approval for Emergency Use in Adolescents

Pfizer Inc. and BioNTech SE disclosed that its COVID-19 vaccine has got the FDA approval for its COVID-19 vaccine. After the approval,...

Soliton [NASDAQ: SOLY] to be Acquired by Allergan Aesthetics

Soliton, Inc. disclosed Monday that it has inked an agreement with Allergen Aesthetics. As per the agreement, Allergen Aesthetics will buy Soliton. Allergen...

The Carlyle Group [NASDAQ: CG] disclosed that it has decided to purchase Unchained Labs for $435 million. Unchained Labs has gained recognition as the fast-growing life sciences tool firm. Since its inception in 2015, its endeavoring to solve the problems of biologics and gene therapy researchers.

The acquisition by The Carlyle Group is a milestone deal for the firm. This deal is beneficial for the firm as it is in start to scratch the surface of biologics and gene therapy chance. The competent team, strong vision, deep know-how, and capital of Carlyle will speed up the organic and inorganic growth of Unchained Labs.

On the other hand, The Carlyle Group has prolonged its commitment to healthcare. The firm has invested more than $16 billion in equity in healthcare since its foundation. Additionally, equity capital for the purchase came from Carlyle Partners VII. An $18.5 billion capital makes majority and strategic minority financings originally in the U.S. in targeted businesses, including healthcare.

Acquisition Details

Furthermore, it has been disclosed that Carlyle has purchased Lab in partnership with its management team, Novo, Canaan Partners, and TPG Biotech. The deal closure is dependent on certain regulatory conditions. Moreover, it is anticipated that the deal will be executed in Q2 2021.

More articles

Latest article

Elon Musk’s SpaceX to Roll Out Dogecoin-Backed Satellite to the Moon in 2022

Elon Musk’s SpaceX has decided to recognize Dogecoin as payment to roll out its “DOGE-1 Mission to the Moon”. The mission is going to...

SBI CEO Yoshitaka Kitao Reveals Ripple to Go Public after its Legal Battle with the SEC is Over

CEO of Japanese financial services company SBI Holdings, Yoshitaka Kitao disclosed that Ripple has opted for an option to go public once its legal...

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...